700,000 Sinopharm vaccines landed in Budapest on Friday
The delivery of 700,000 Sinopharm vaccines marks the fulfilment of China’s contract with Hungary.
The delivery of 700,000 Sinopharm vaccines marks the fulfilment of China’s contract with Hungary.
WHO’s approval of the jab created a new situation in the fight against the pandemic, ahead of the approaching global health meeting of G20 countries.
Hungary's national vaccination program has allowed a gradual reopening of the country.
The Sinopharm vaccine produces many hundred times the number of antibodies after two jabs than that after someone is infected by the virus.
The past few months had seen “extremely effective cooperation” between China and Hungary.
NNK is examining China’s Sinopharm vaccine, 550,000 doses of which were delivered to Hungary on Tuesday.
Vaccinations using the Sinopharm jab will be available once NNK has tested and authorized it for general use.
550,000 doses of the vaccine will be loaded on the state aircraft which is expected to return to Hungary at around noon today.
More than 30 million people have so far been inoculated with the Sinopharm vaccine worldwide, including ethnic Hungarians living in Serbia.
Péter Szijjártó said he had signed an agreement to purchase the vaccine, enough to inoculate 2.5 million people, on Friday.
A senior official at Hungary’s National Institute of Pharmacy and Nutrition (OGYÉI) has confirmed that the Chinese Sinopharm vaccine is being manufactured under safe conditions.
Gergely Gulyás said 129,860 vaccine doses have arrived from the EU so far, and 91,600 people have received their shots.